0001593968-22-001520.txt : 20221012
0001593968-22-001520.hdr.sgml : 20221012
20221012215948
ACCESSION NUMBER: 0001593968-22-001520
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220701
FILED AS OF DATE: 20221012
DATE AS OF CHANGE: 20221012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Yeh Wen-Chen
CENTRAL INDEX KEY: 0001873360
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39635
FILM NUMBER: 221307991
MAIL ADDRESS:
STREET 1: 171 OYSTER POINT BLVD., SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Surrozen, Inc./DE
CENTRAL INDEX KEY: 0001824893
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 981556622
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 171 OYSTER POINT BLVD
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-475-2820
MAIL ADDRESS:
STREET 1: 171 OYSTER POINT BLVD
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Consonance-HFW Acquisition Corp.
DATE OF NAME CHANGE: 20200915
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2022-07-01
0001824893
Surrozen, Inc./DE
SRZN
0001873360
Yeh Wen-Chen
C/O SURROZEN, INC.
171 OYSTER POINT BLVD., SUITE 400
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
Chief Scientific Officer
Option (right to buy)
10.77
2022-10-10
4
D
false
29567
D
2021-02-01
2031-02-22
Common Stock
29567
0
D
Option (right to buy)
10.77
2022-10-10
4
D
false
5562
D
2021-02-01
2031-02-22
Common Stock
5562
0
D
Option (right to buy)
3.15
2022-07-01
4
A
false
500
0
A
2022-07-21
2032-07-01
Common Stock
500
500
D
Option (right to buy)
2.16
2022-10-10
4
A
false
5562
A
2021-02-01
2031-02-22
Common Stock
5562
5562
D
Option (right to buy)
2.16
2022-10-10
4
A
false
29567
A
2021-02-01
2031-02-22
Common Stock
29567
29567
D
The reporting person agreed to cancellation of an option granted to him on February 23, 2021, in exchange for a new option having a lower exercise price.
The shares subject to the options vest and become exercisable in a series of 48 equal monthly installments beginning on 2/1/2021, subject to the reporting person's continued employment through the applicable vesting date.
The shares subject to the options vest and become exercisable in a series of 48 equal monthly installments beginning on 7/21/2022, subject to the reporting person's continued employment through the applicable vesting date.
/s/Sheela Mohan-Peterson, Attorney-in-Fact for Wen-Chen Yeh
2022-10-12